Mavupharma

Mavupharma is a drug discovery and development company focused on novel approaches to selectively target the STING (stimulator of interferon genes) pathway, harnessing the innate immune system to treat cancer and infectious diseases. The company was founded by Frazier, and its leadership team includes Frazier senior advisor Mike Gallatin and Frazier EIRs Bob Baltera and Brian Farmer.